No long-term evidence of hyporesponsiveness following the use of pneumococcal conjugate vaccine in children previously immunised with pneumococcal polysaccharide vaccine

BACKGROUND: A randomised controlled trial in Fiji examined the immunogenicity and impact on nasopharyngeal carriage following 0, 1, 2 or 3 doses of pneumococcal conjugate vaccine (PCV7) in infancy followed by 23-valent pneumococcal polysaccharide (23vPPV) vaccine at 12 months of age. At 18 months of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Allergy Clin Immunol
Autores principales: Licciardi, Paul V, Toh, Zheng Quan, Clutterbuck, Elizabeth A, Balloch, Anne, Marimla, Rachel A, Tikkanen, Leena, Lamb, Karen E, Bright, Kathryn J, Rabuatoka, Uraia, Tikoduadua, Lisi, Boelsen, Laura K, Dunne, Eileen M, Satzke, Catherine, Cheung, Yin Bun, Pollard, Andrew J, Russell, Fiona M, Mulholland, Edward K
Formato: Artigo
Lenguaje:Inglês
Publicado: 2016
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4899320/
https://ncbi.nlm.nih.gov/pubmed/26825000
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2015.12.1303
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares